<DOC>
	<DOCNO>NCT00243529</DOCNO>
	<brief_summary>Dendritic cell ( DCs ) potent antigen-presenting cell immune system , able direct immune system specifically cancer cell . Currently DCs use clinical vaccination study immunological clinical response observe . For induce anti-tumor immunity , DCs load tumor antigen ( i.e . molecular structure present tumor , recognize immune system ) . Currently study use tumor peptide ( small protein fragment ) purpose . This approach several disadvantage : patient certain HLA-type treat immune response induce vaccine limit use peptide . These disadvantage exist DCs present antigen endogenously process , example RNA transfection . For reason investigate immunogenicity DCs pulse peptide transfected mRNA encode melanoma associate antigen stage III IV melanoma patient .</brief_summary>
	<brief_title>Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines Melanoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>For stage III IV Histological proof cutaneous melanoma Melanoma express gp100 tyrosinase , approximately 20 % cell immunohistochemistry staining , HLA type A2 and/or A3 , know HLADR4 expression , WBC &gt; 3.0 x 109/l , lymphocytes &gt; 0.8 x 109/l , platelet &gt; 100 x 109/l , serum creatinine &lt; 150 μmol/l , serum bilirubin &lt; 25 μmol/l . Expected adequacy followup , Written inform consent . For Stage III Stage III melanoma accord 2001 AJCC criterion . Start treatment within 2 month lymph node dissection melanoma stage III For stage IV Stage IV melanoma accord 2001 AJCC criterion . Limited tumor burden ; LDH &lt; 2x upper limit normal For stage III IV No autoimmune disorder , concomitant use immunosuppressive drug , serious concomitant disease , serious active infection , malignancy past 5 year exception curatively treat carcinoma insitu cervix/squamous cell carcinoma skin , No known allergy shell fish ( contains KLH ) exclude . No pregnancy lactation , For stage III : No sign symptom distant metastasis define normal history , physical examination , chest Xray serum LDH . No concomitant previous systemic treatment melanoma For stage IV : No clinical sign CNS metastasis , patient clinical suspicion CNS metastasis , CT scan brain perform exclude . No prior chemotherapy , immunotherapy , radiotherapy within three month plan vaccination allow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Dendritic cell</keyword>
	<keyword>Melanoma</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>RNA</keyword>
	<keyword>Peptides</keyword>
</DOC>